Formus Labs has successfully raised $5 million to enhance its automated orthopedic surgery planning platform and establish a partnership with Zimmer Biomet for global market expansion.
Target Company Overview
Formus Labs, headquartered in Auckland, New Zealand, is a pioneering company in the field of orthopedic surgery planning. It has developed the world’s first automated 3D planning software tailored specifically for joint replacement surgeries. The Formus platform integrates artificial intelligence and biomechanics to provide orthopedic surgeons with fully interactive 3D models, enhancing the preoperative planning process and optimizing outcomes for patients.
This innovative software not only automates the planning stages but also enables surgeons to create personalized surgical plans tailored to the unique anatomy of each patient. By significantly improving efficiency, Formus Labs aims to address the notable challenges faced in joint replacement procedures, such as variability in outcomes and the high costs associated with revision surgeries.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in New Zealand
The orthopedic surgical market in New Zealand is a critical segment of the healthcare sector, driven by an increasing aging population and a rising prevalence of conditions requiring joint replacements. An estimated one in five knee
Similar Deals
Pacific Channel → Upstream Medical Technologies
2023
GD1
invested in
Formus Labs
in 2023
in a Seed Stage deal
Disclosed details
Transaction Size: $5M